SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001583648-19-000036
Filing Date
2019-06-18
Accepted
2019-06-18 16:07:33
Documents
5
Effectiveness Date
2019-06-18

Document Format Files

Seq Description Document Type Size
1 DEFA14A pirs2019proxynotice.htm DEFA14A 9229
2 a190613proxynoticepage1a01.jpg GRAPHIC 147110
3 a190613proxynoticepage2a01.jpg GRAPHIC 237752
4 a190613proxynoticepage3a01.jpg GRAPHIC 86693
5 a190613proxynoticepage4a01.jpg GRAPHIC 52043
  Complete submission text file 0001583648-19-000036.txt   732040
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37471 | Film No.: 19903748
SIC: 8731 Services-Commercial Physical & Biological Research